These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14748094)

  • 21. National health spending in 2011: overall growth remains low, but some payers and services show signs of acceleration.
    Hartman M; Martin AB; Benson J; Catlin A;
    Health Aff (Millwood); 2013 Jan; 32(1):87-99. PubMed ID: 23297275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug coverage insurance as a novel element of private health insurance in Poland.
    Czerw A; Religioni U
    Acta Pol Pharm; 2013; 70(4):763-7. PubMed ID: 23923401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of healthcare delivery privatisation on avoidable mortality: longitudinal cross-regional results from Italy, 1993-2003.
    Quercioli C; Messina G; Basu S; McKee M; Nante N; Stuckler D
    J Epidemiol Community Health; 2013 Feb; 67(2):132-8. PubMed ID: 23024258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health expenditure trends in OECD countries, 1970-1997.
    Huber M
    Health Care Financ Rev; 1999; 21(2):99-117. PubMed ID: 11481789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of pharmaceutical policy measures: an endogenous structural-break approach.
    Barros PP; Nunes LC
    Soc Sci Med; 2010 Aug; 71(3):440-450. PubMed ID: 20621744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in Insulin Out-of-Pocket Costs and Reimbursement Price Among US Patients With Private Health Insurance, 2006-2017.
    Meiri A; Zhang F; Ross-Degnan D; Wharam JF
    JAMA Intern Med; 2020 Jul; 180(7):1010-1012. PubMed ID: 32478823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced diagnostic imaging in privately insured patients: recent trends in utilization and payments.
    Horný M; Burgess JF; Horwitt J; Cohen AB
    J Am Coll Radiol; 2014 Jul; 11(7):692-7. PubMed ID: 24813748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health spending in OECD countries: obtaining value per dollar.
    Anderson GF; Frogner BK
    Health Aff (Millwood); 2008; 27(6):1718-27. PubMed ID: 18997231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.
    Sulzbach S; De S; Wang W
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i72-84. PubMed ID: 21729920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Private expenditure and the role of private health insurance in Greece: status quo and future trends.
    Siskou O; Kaitelidou D; Economou C; Kostagiolas P; Liaropoulos L
    Eur J Health Econ; 2009 Oct; 10(4):467-74. PubMed ID: 19593628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in public spending on health slowed in 2010, as private health spending rose.
    Limb M
    BMJ; 2012 May; 344():e3246. PubMed ID: 22569870
    [No Abstract]   [Full Text] [Related]  

  • 32. A note on cointegration of health expenditures and income.
    Wang Z; Rettenmaier AJ
    Health Econ; 2007 Jun; 16(6):559-78. PubMed ID: 17039571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
    Chen LC; Schafheutle EI; Noyce PR
    Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National health spending in 2007: slower drug spending contributes to lowest rate of overall growth since 1998.
    Hartman M; Martin A; McDonnell P; Catlin A;
    Health Aff (Millwood); 2009; 28(1):246-61. PubMed ID: 19124877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. US spending on prescription drugs rose by 19% in 2000.
    Charatan F
    BMJ; 2001 May; 322(7296):1198. PubMed ID: 11358763
    [No Abstract]   [Full Text] [Related]  

  • 36. The Growing Difference Between Public And Private Payment Rates For Inpatient Hospital Care.
    Selden TM; Karaca Z; Keenan P; White C; Kronick R
    Health Aff (Millwood); 2015 Dec; 34(12):2147-50. PubMed ID: 26643636
    [No Abstract]   [Full Text] [Related]  

  • 37. A roadmap to parity in mental health financing: the case of Lebanon.
    Yehia F; Nahas Z; Saleh S
    J Ment Health Policy Econ; 2014 Sep; 17(3):131-41. PubMed ID: 25543116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The political economy of the public-private mix in heath expenditure: an empirical review of thirteen OECD countries.
    Mou H
    Health Policy; 2013 Dec; 113(3):270-83. PubMed ID: 23910734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Private health care expenditure and quality in Beveridge systems: cross-regional differences in the Italian NHS.
    Del Vecchio M; Fenech L; Prenestini A
    Health Policy; 2015 Mar; 119(3):356-66. PubMed ID: 25467792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.